Welcome to MyBRISK Impact, our biannual eNews highlighting the latest activities of the MyBRISK Centre for Research Excellence (CRE) on breast cancer screening.
If you have news, research, findings and upcoming events you’d like to share, please email mybrisk-cre@unimelb.edu.au
|
Update on research with twins
|
As reported in our last issue, the MyBRISK CRE is rolling out a novel study. In collaboration with Twins Research Australia and the Bowel Cancer Screening Alliance, we are harnessing the special opportunities that arise from studying both identical and non-identical twin pairs to gain a better understanding of cancer screening across the whole population. To date, we have received responses from 3,921 individual twins (including 1,408 twin pairs). Recruitment is ongoing and data analysis will commence in the next month or so.
|
World’s largest map of breast tissue
|
A new study, led by researchers at the University of Texas and University of California, has created the world's largest and most comprehensive map of breast tissue, providing an unprecedented understanding of mammary biology that may help identify therapeutic targets for diseases such as breast cancer.
Learn more
|
MyBRISK collaborates with commercial partners
|
MyBRISK Director, Professor John Hopper, was recently invited to speak at the annual Siemens Healthcare Mammography User Group Meeting, attended by more than 30 radiographers working in breast imaging in Australia and New Zealand. His presentation highlighted the purpose and aims of the MyBRISK CRE, how radiographers are involved in the program, and how outcomes could improve the prevention, detection, and treatment of breast cancer.
This opportunity has widened our stakeholder involvement which now includes more practitioners from magnetic resonance imaging and ultrasound, as well as mammographic screening.
|
National review of breast cancer risk assessment tools
|
The ROSA project (Roadmap for Optimising Screening in Australia) has concluded and published its review of breast cancer risk assessment tools for stratifying women into risk groups. ROSA was led by Cancer Council Australia and funded by the Australian Government. Its research aimed to grow evidence about the accuracy and effectiveness of breast cancer risk assessment, of increasing use of different breast imaging technologies outside BreastScreen, and of community interest about breast cancer risk factors including breast density.
Read the review
|
BreastScreen SA introduces breast density reporting
|
South Australian women will soon be able to learn their individual breast density at all 11 BreastScreen SA clinics after a study found women had a strong preference to be more informed as part of their regular screening. The survey found more than 90 per cent of respondents would like to continue to be informed of their breast density, with just two per cent preferring not to be told as part of their future appointments.
Article here
|
Co-evolution of epidemiology and AI: challenges and opportunities
|
How can researchers facilitate the co-evolution of epidemiology and AI, and ensure population health is the true beneficiary? This question is explored in an International Journal of Epidemiology editorial by MyBRISK CIA Professor John Hopper and Seoul National University AI Professor Joohon Sung. “A key aim of our editorial was to generate a series of papers on this important topic and to encourage others to write articles on any aspect of the ‘collision’ between these two approaches,” Professor Hopper said.
“The key difference between AI and classic epidemiology is that the latter builds models based on explicit assumptions about what matters and how, so that the results can be directly interpretable, whereas AI builds algorithms in essence for predictive models discovered from the data, without necessarily understanding why.”
Editorial here
|
Can AI improve breast cancer survival rates?
|
The Conversation recently featured an article, AI Can Help Detect Breast Cancer. But We Don’t Yet Know If It Can Improve Survival Rates, by our colleague and MyBRISK Advisor, Professor Christobel Saunders, the James Stewart Chair of Surgery, and Head of the Department of Surgery (Royal Melbourne Hospital precinct).
Article here
|
|
|
